Global Infertility Market Growth (Status and Outlook) 2023-2029

Global Infertility Market Growth (Status and Outlook) 2023-2029

In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.

LPI (LP Information)' newest research report, the “Infertility Industry Forecast” looks at past sales and reviews total world Infertility sales in 2022, providing a comprehensive analysis by region and market sector of projected Infertility sales for 2023 through 2029. With Infertility sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infertility industry.

This Insight Report provides a comprehensive analysis of the global Infertility landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infertility portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infertility market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infertility and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infertility.

The global Infertility market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Estimates from 1997 suggest that worldwide about five percent of all heterosexual couples have an unresolved problem with infertility. Many more couples, however, experience involuntary childlessness for at least one year: estimates range from 12% to 28%. 20-30% of infertility cases are due to male infertility, 20-35% are due to female infertility, and 25-40% are due to combined problems in both parts. In 10-20% of cases, no cause is found.

This report presents a comprehensive overview, market shares, and growth opportunities of Infertility market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Assisted Reproductive Technology (ART)
Artificial Insemination
Fertility Surgeries

Segmentation by application
Male
Female

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
The Cooper Companies
Cook Group
Thermo Fisher Scientific
Vitrolife
Esco Micro
Genea
Irvine Scientific
Ivftech
The Baker Company
Kitazato
Rinovum Women’s Health
Rocket Medical
Ihmedical

Please note: The report will take approximately 2 business days to prepare and deliver.